Las Vegas, NV -- (SBWIRE) -- 10/01/2013 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Kandi Technologies Group Inc (NASDAQ:KNDI), Glu Mobile Inc. (NASDAQ:GLUU), Cell Therapeutics Inc (NASDAQ:CTIC), Gogo Inc (NASDAQ:GOGO).
Kandi Technologies Group Inc (NASDAQ:KNDI) managed to keep its fall at -3.23% on traded volume of 5.09 million shares. The stock settled at $7.78 after floating in a range of $7.51 to $8.43. After recent close, it has reached market capitalization of $287.61 million. Its 52-week range has been $3.37 to $9.20. Kandi Technologies Group, Inc., through its subsidiaries, engages in the design, development, manufacture, and commercialization of various vehicles.
Will KNDI Get Buyers Even After The Recent Rally? Find Out Here
Glu Mobile Inc. (NASDAQ:GLUU) traded down on a volume of 3.29 million, higher than its standard daily volume. Shares have dropped -1.38% to $2.78. Over the last twelve months the stock has lost -40.06% and faced a worst price of $2.64. Glu Mobile Inc. develops and publishes a portfolio of action/adventure and casual games for the users of smart phones and tablet devices. The company develops games based on its own brands, including Blood & Glory, Big Time Gangsta, Contract Killer, and Contract Killer: Zombies, Deer Hunter, Eternity Warriors, Frontline Commando, Gun Bros, Samurai vs.
Will GLUU Get Buyers Even After The Recent Rally? Find Out Here
Cell Therapeutics Inc (NASDAQ:CTIC) settled -2.93% lower at $1.62 on traded volume of 4.21 million shares during the last trading day, while its average trading volume remained 2.32 million shares. The stock has its 12-month low at $0.97 and 52-week high price was $2.75. It traded in a range of $1.60 to $1.68 during the last trading day. Cell Therapeutics, Inc. engages in the acquisition, development, and commercialization of treatments for cancer. The company primary focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in Phase III clinical trials for the treatment of multiply relapsed or refractory aggressive non-Hodgkin lymphoma.
Will CTIC Get Buyers Even After The Recent Rally? Find Out Here
Gogo Inc (NASDAQ:GOGO) saw its price fall on traded volume 2.19 million shares changed hands when compared with its average daily volume of 1.15 million shares. The stock was down -4.26% to $17.77. It has gained over the last 12 months, increasing 11.06% and marked new low $9.71. Gogo Inc. provides in-flight Internet connectivity and wireless in-cabin digital entertainment solutions in the United States and internationally. The company operates through Commercial Aviation and Business Aviation segments.
Will GOGO Get Buyers Even After The Recent Rally? Find Out Here
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)